- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 859.72M sh |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $10.37B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $10.51B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.82B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.05B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $14.77B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $15.04B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.53B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $12.38B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $25.18B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $25.59B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.62B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $2.26B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 891M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $250M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $151M |
| Capex | Q1 2025 · Mar 31, 2024 | $330M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $487M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.68 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.68 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $61M |
| Net Income | Q1 2025 · Mar 31, 2024 | $606M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $987M |